Fortress Investment Group LLC Grows Stock Holdings in Omada Health, Inc. $OMDA

Fortress Investment Group LLC boosted its holdings in Omada Health, Inc. (NASDAQ:OMDA) by 43.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 225,000 shares of the company’s stock after buying an additional 67,750 shares during the quarter. Omada Health makes up about 0.7% of Fortress Investment Group LLC’s holdings, making the stock its 26th largest position. Fortress Investment Group LLC owned 0.39% of Omada Health worth $4,975,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Divisadero Street Capital Management LP purchased a new stake in Omada Health during the 3rd quarter worth about $30,510,000. Bellevue Group AG increased its holdings in shares of Omada Health by 0.7% in the 3rd quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock valued at $5,567,000 after acquiring an additional 1,791 shares during the last quarter. Two Sigma Investments LP raised its position in shares of Omada Health by 352.2% during the 3rd quarter. Two Sigma Investments LP now owns 45,219 shares of the company’s stock worth $1,000,000 after acquiring an additional 35,219 shares in the last quarter. UBS Group AG lifted its stake in Omada Health by 14.9% during the third quarter. UBS Group AG now owns 43,484 shares of the company’s stock worth $961,000 after purchasing an additional 5,626 shares during the last quarter. Finally, BNP Paribas Financial Markets purchased a new stake in Omada Health during the third quarter worth approximately $278,000.

Omada Health Stock Up 3.6%

NASDAQ:OMDA opened at $14.53 on Monday. The company has a market capitalization of $856.11 million and a PE ratio of -85.47. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $28.40. The stock’s 50 day moving average price is $13.89 and its 200 day moving average price is $18.39.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings data on Thursday, March 5th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.12. The firm had revenue of $75.85 million during the quarter.

Insider Buying and Selling at Omada Health

In related news, CEO Sean P. Duffy sold 4,063 shares of the company’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $14.34, for a total value of $58,263.42. Following the completion of the sale, the chief executive officer owned 117,598 shares in the company, valued at $1,686,355.32. This represents a 3.34% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, President Wei-Li Shao sold 5,618 shares of the stock in a transaction on Monday, December 29th. The stock was sold at an average price of $16.13, for a total transaction of $90,618.34. Following the sale, the president owned 69,079 shares of the company’s stock, valued at approximately $1,114,244.27. This represents a 7.52% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 280,956 shares of company stock valued at $4,395,050.

Wall Street Analysts Forecast Growth

Several brokerages have commented on OMDA. Morgan Stanley dropped their price target on shares of Omada Health from $32.00 to $30.00 and set an “overweight” rating on the stock in a research note on Friday, March 6th. JPMorgan Chase & Co. reduced their price objective on shares of Omada Health from $32.00 to $26.00 and set an “overweight” rating for the company in a research report on Thursday. Barclays lowered their target price on shares of Omada Health from $22.00 to $17.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. BMO Capital Markets cut their price target on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a research note on Friday, March 6th. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $26.00 price target on shares of Omada Health in a research report on Friday, January 16th. Eight investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Omada Health presently has a consensus rating of “Moderate Buy” and an average price target of $23.60.

Omada Health Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.